Bacteremia
📧 Sign up to get email alerts when something new happens for Bacteremia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Epidemiology of Antimicrobial-use and Antimicrobial-resistant Infections in Four Hospitals in Thailand
A clinical trial update assessing the epidemiology of antimicrobial use and antimicrobial-resistant infections across four hospitals in Thai…
-
CLINICAL_TRIALS withdrawal · 2025-07-24Clinical Trial Update: PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections [Phase 4]
A Phase 4 trial comparing pipercillin/tazobactam against meropenem for AmpC-producing bloodstream infections has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use [Phase 4]
Phase 4 trial evaluating anchoring sequential intermittent long-acting antimicrobials with medication-assisted treatment for opioid use diso…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK)
Completed clinical trial evaluating pharmacokinetic parameters of vancomycin derived from a medical device. The study investigates how a dev…
-
CLINICAL_TRIALS research · 2025-05-14Clinical Trial Update: Initial Feasibility Study of the CycloPE® Device [NA]
This clinical trial update notes an initial feasibility study of the CycloPE device for sepsis-related conditions; the trial is currently ac…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
A clinical trial update describing a study on monocyte distribution width (MDW) as a biomarker in emergency department patients with and wit…
-
FDA approval · 2025-04-30FDA Approved: DAPTOMYCIN IN SODIUM CHLORIDE — Supplemental Application (Baxter Healthcare Corporation)
FDA approves Baxter's supplemental application for daptomycin in sodium chloride, adding a saline formulation of the antibiotic.
-
FDA approval · 2025-04-30FDA Approved: DAPTOMYCIN — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for daptomycin submitted by Civica, Inc.
-
CLINICAL_TRIALS research · 2025-04-02Clinical Trial Update: The Clinical Impact of Cobas® Eplex Blood Culture Panels for the Diagnosis of Bacteremia and Fungemia [NA]
This clinical trial update evaluates the clinical impact of Cobas Eplex Blood Culture Panels for diagnosing bacteremia and fungemia. The stu…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: Machine Learning Assisted Electrochemical Profiling to Provide Early Identification of Bloodstream Infections Pathogens [NA]
This clinical trial investigates using machine learning-assisted electrochemical profiling to rapidly identify pathogens causing bloodstream…
-
CLINICAL_TRIALS trial_result · 2025-03-13Clinical Trial Update: Outcomes of Empiric Antibiotic Therapy Based on Hospital Antibiograms in Organ Transplant Recipients with Bacteraemia
This clinical trial evaluates outcomes of empiric antibiotic therapy guided by hospital antibiograms in organ transplant recipients with bac…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Surveillance of AMR in DRC
A University of Oxford-sponsored surveillance trial in the Democratic Republic of the Congo is monitoring antimicrobial resistance in patien…
-
CLINICAL_TRIALS trial_result · 2024-11-21Clinical Trial Update: Mortality of MBL-producing Enterobacteriaceae Bacteremias with the Combined Use of Ceftazidime-avibactam and Aztreonam Vs. Other Active Antibiotics. a Multicenter Target Trial Emulation.
A multicenter target trial emulation comparing mortality outcomes of combining ceftazidime-avibactam with aztreonam versus other active anti…
-
FDA approval · 2024-11-21FDA Approved: DAPTOMYCIN — Original Application (Par Health USA, LLC)
FDA approves the original application for daptomycin by Par Health USA, LLC, authorizing its use as an antibiotic for certain serious infect…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: Resistell Phenotech AST to Determine the Antibiotic Susceptibility of Gram-negative Bacteria Causing Bacteremia
The Resistell AG trial NCT05613322 evaluating the Resistell Phenotech AST for determining antibiotic susceptibility in Gram-negative bacteri…
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults [Phase 4]
Phase 4 trial results evaluate the efficacy and safety of ceftazidime-avibactam (CAZ-AVI) for carbapenem-resistant Gram-negative infections …
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Knowledge Attitude and Practice Regarding Bloodstream Bacterial Infections and Antibiotics Usage Among Doctors.
ClinicalTrials.gov update describing an enrolling-by-invitation study evaluating physicians' knowledge, attitudes, and practices surrounding…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Rapid Antimicrobial Susceptibility Testing with MIC Directly from Positive Blood Cultures with ASTar [NA]
A completed clinical trial evaluating rapid MIC-based antimicrobial susceptibility testing directly from positive blood cultures using the A…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Process Mapping and Data Collection to Inform a Computer Simulation Model of Hospitalised Patients With Bloodstream Infection, Sepsis and Systemic Infection
This clinical trial update outlines methods for process mapping and data collection to inform a computer simulation model of hospitalised pa…
-
FDA approval · 2024-08-29FDA Approved: DAPTOMYCIN — Original Application (Biocon Pharma Inc.)
FDA approved Biocon Pharma Inc.'s original application for daptomycin (DAPTOMYCIN), a generic antibiotic.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Bloodstream Infection of Carbapenem-Resistant Proteus Mirabilis
A completed clinical trial evaluating treatment for bloodstream infection caused by carbapenem-resistant Proteus mirabilis. The study, spons…
-
CLINICAL_TRIALS trial_result · 2024-07-08Clinical Trial Update: Continuous Temperature Telemonitoring of Patients With COVID-19 and Other Infectious Diseases in Hospital at Home Using Viture
A completed clinical trial update on continuous temperature telemonitoring for COVID-19 and other infectious diseases in hospital-at-home se…
-
CLINICAL_TRIALS trial_result · 2024-06-21Clinical Trial Update: Predictive Value of Procalcitonin for Bacteremia in the ICU
Completed clinical study evaluating whether procalcitonin can predict bacteremia in ICU patients with sepsis.
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: An Oral Doxycycline Regimen to Prevent Bacteremia Following Dental Procedures [Phase 4]
A Phase 4 clinical trial is evaluating whether an oral doxycycline regimen can prevent bacteremia after dental procedures. The study is not …
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Rapid Blood Culture Identification Panel in Pediatric Patients in Guatemala [NA]
This completed clinical trial in Guatemala evaluated a Rapid Blood Culture Identification Panel in pediatric patients with bacteremia or sep…